NEW YORK, April 17, 2017 /PRNewswire/ -- The Standard Homeopathic Company has issued a recall for all lots of Hyland's Baby Teething Tablets and Hyland's Baby Nighttime Teething Tablets, after the U.S. Food & Drug Administration (FDA) confirmed that the products contained excessive levels of potentially toxic belladonna. Consumers with these medications in their possession should contact Standard Homeopathic at 1-800-991-3376 (Monday-Friday 6 a.m. to 4 p.m. Pacific Time).
Children who ingest too much belladonna are at risk for seizures and other potentially life-threatening adverse events. Parents and caregivers should avoid using Hyland's Teething Tablets to treat teething pain in infants and children. Contact a doctor if a child experiences breathing difficulty, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating or agitation following ingestion of a homeopathic teething remedy.
"The FDA issued its first warning for homeopathic teething tablets and gels last fall, after such products were linked to 10 infant deaths and hundreds of adverse events, We are pleased that the agency continues to work to mitigate the risks posed by these medications," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to families whose children may have been harmed by homeopathic teething medications.
Teething Tablets Warnings and Recalls
Following the FDA's warning last September, several retailers moved to pull homeopathic teething remedies from their store shelves. Standard Homeopathic announced that it would stop marketing Hyland's teething tablets in the U.S. However, the company's products were not officially recalled.
In November, Raritan Pharmaceuticals announced a recall of its homeopathic teething tablets and ear pain liquids after tests suggested they might contain varying amounts of belladonna.
The FDA issued a warning specific to Hyland's teething tablets in January, after the agency determined that the products contained inconsistent levels of belladonna, possibly in excess of the amount claimed on the label. The FDA formally asked Standard Homeopathic to issue a teething tablets recall on April 10th.
This is not the first time Hyland's products have been found to contain inconsistent amounts of belladonna. Hyland's homeopathic teething remedies were also recalled in 2010, after they were linked to adverse events suggestive of belladonna poisoning.
Infants and children who suffered complications allegedly related to homeopathic teething medications may be entitled to compensation for injury-related damages. To learn more about filing a teething tablets lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hylands-teething-tablets-recall-announced-after-fda-confirms-high-levels-of-potentially-toxic-belladonna-bernstein-liebhard-llp-reports-300440328.html
SOURCE Bernstein Liebhard LLP